Pathology Managed Service – Preliminary Market Engagement

Gloucestershire Hospitals NHS Foundation Trust, an NHS healthcare provider, is preparing a competitive procurement for a managed pathology service covering its Blood Sciences, Infection Sciences and Cellular Pathology operations. The supplier will provide and operate laboratory analytical platforms, automation, point-of-care devices and related instrumentation, together with reagents, consumables, maintenance, software and middleware, training, lifecycle replacement and enabling works to prepare laboratory space. The service is expected to begin across existing laboratories at Gloucestershire Royal Hospital and Cheltenham General Hospital, then support consolidation into a new-build pathology hub, with the final hub location and associated acute-site resilience model still under consideration. The estimated contract value is £150 million, although the contract duration is not stated, and delivery will be in Gloucestershire, within the UKK13 region. The critical qualification requirement is not specified in the available preliminary market engagement information; detailed eligibility requirements are expected to be established through the subsequent competitive procurement.

Buyer: Gloucestershire Hospitals NHS Foundation Trust. Source: Find a Tender. Updated 16 Nov 2026.

Key facts

  • Estimated value: £150m
  • Bids close: Not open for bids yet
  • Location: Gloucestershire
  • Contract period: 3 Jul 2028 to 3 Jul 2040
  • Category: Laboratory services (71900000)

From the official notice

Gloucestershire Hospitals NHS Foundation Trust (“the Authority”) is undertaking preliminary market engagement ahead of a competitive procurement for a Pathology Managed Service. The intended contract will provide, as a managed service, the laboratory equipment (analytical platforms, automation, point-of-care devices and associated instrumentation), reagents, consumables, maintenance, software/middleware, training and lifecycle replacement required to deliver the Authority’s pathology service. The service is expected to be structured in two phases: Phase 1 covering the Authority’s existing laboratories at Gloucestershire Royal Hospital and Cheltenham General Hospital, and Phase 2 following consolidation into a new-build pathology hub. The Authority’s working direction is a new-build hub with the location not yet determined; two options remain under consideration, each with implications for the service model that suppliers should allow for: A hub on the Gloucester (hospital) site would require continued urgent haematology and clinical chemistry provision at Cheltenham General. An off-site hub would require acute (hot lab) provision and resilience at both Gloucestershire Royal and Cheltenham General. Transfusion provision should not be assumed at all three locations (remote issue, transport, storage, space and staffing remain dependencies); for microbiology, an off-site hub may require on-site blood-culture loading at the acute sites and further review of patient-facing sample c...

View the official notice

Questions about this tender

When is the deadline?

Bidding has not opened yet. The buyer has published it as a planned tender.

What is it worth?

The estimated value is £150m.

Who can apply?

The buyer has marked it as suitable for small and medium-sized businesses.

How do I bid?

You cannot bid yet. Follow the official notice for the competition that comes next, and check how the buyer's portal lets suppliers register.

Similar tenders

Contains public sector information licensed under the Open Government Licence v3.0.

See all live tenders